aDivision of Epidemic Intelligence Service, Korea Centers for Disease Control and Prevention, Cheongju, Korea
bDepartment of Internal Medicine, College of Medicine, Catholic University of Korea, Seoul, Korea
© 2014 Published by Elsevier B.V. on behalf of Korea Centers for Disease Control and Prevention.
This is an Open Access article distributed under the terms of the CC-BY-NC License (http://creativecommons.org/licenses/by-nc/3.0).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Total (no.) | Men (no.) | Women (no.) | p | ||
---|---|---|---|---|---|
Age (y) | 0–9 | 214 | 113 | 101 | < 0.0001 |
10–19 | 2,443 | 1,490 | 953 | ||
20–29 | 8,134 | 4,263 | 3,871 | ||
30–39 | 7,299 | 4,510 | 2,789 | ||
40–49 | 7,338 | 5,251 | 2,087 | ||
50–59 | 5,675 | 4,148 | 1,527 | ||
60–69 | 6,293 | 4,236 | 2,057 | ||
≥ 70 | 8,038 | 4,197 | 3,841 | ||
Region | 1 | 12,085 | 7,309 | 4,776 | < 0.0001 |
2 | 4,531 | 2,799 | 1,732 | ||
3 | 2,155 | 1,364 | 791 | ||
4 | 1,854 | 1,186 | 668 | ||
5 | 1,386 | 850 | 536 | ||
6 | 1,048 | 637 | 411 | ||
7 | 681 | 432 | 249 | ||
8 | 6,747 | 4,221 | 2,526 | ||
9 | 2,130 | 1,206 | 924 | ||
10 | 1,265 | 787 | 478 | ||
11 | 1,841 | 1,205 | 636 | ||
12 | 2,101 | 1,329 | 772 | ||
13 | 1,946 | 1,247 | 699 | ||
14 | 2,106 | 1,284 | 822 | ||
15 | 3,157 | 2,089 | 1,068 | ||
16 | 401 | 263 | 138 | ||
Registration | New | 34,569 | 20,631 | 13,938 | < 0.0001 |
Type | Relapse | 5,611 | 4,095 | 1,516 | |
T.A.F. | 283 | 214 | 69 | ||
T.A.D. | 654 | 496 | 158 | ||
T.I. | 1,812 | 1,125 | 687 | ||
Other | 2,505 | 1,647 | 858 | ||
Tuberculosis type | Sputum smear (+) pul TB | 15,745 | 10,251 | 5,494 | < 0.0001 |
Sputum smear (−) pul TB | 23,437 | 14,773 | 8,700 | ||
Extrapulmonary TB | 6,216 | 3,184 | 3,032 | ||
Medication | Only Group 1 drugs | 43,276 | 26,757 | 16,519 | < 0.0001 |
With Groups 2–5 drugs | 2,158 | 1,451 | 707 | ||
Total | 45,434 | 28,208 | 17,226 |
Relapse | p | |||||
---|---|---|---|---|---|---|
No | Yes | |||||
Sex | Men | 25,145 | (89.14) | 3,063 | (10.86) | < 0.0001 |
Women | 15,918 | (92.41) | 1,308 | (7.59) | ||
Age (y) | 0–9 | 207 | (96.73) | 7 | (3.27) | < 0.0001 |
10–19 | 2,256 | (92.35) | 187 | (7.65) | ||
20–29 | 7,417 | (91.19) | 717 | (8.81) | ||
30–39 | 6,583 | (90.19) | 716 | (9.81) | ||
40–49 | 6,494 | (88.50) | 844 | (11.50) | ||
50–59 | 5,092 | (89.73) | 583 | (10.27) | ||
60–69 | 5,662 | (89.97) | 631 | (10.03) | ||
≥ 70 | 7,352 | (91.47) | 686 | (8.53) | ||
Medical | Public | 11,412 | (91.03) | 1,124 | (8.97) | 0.0004 |
Facilities | Private | 29,651 | (90.13) | 3,247 | (9.87) | |
Registration | New | 31,756 | (91.86) | 2,813 | (8.14) | < 0.0001 |
Type | Relapse | 4,772 | (85.05) | 839 | (14.95) | |
T.A.F. | 222 | (78.45) | 61 | (21.55) | ||
T.A.D. | 490 | (74.92) | 164 | (25.08) | ||
T.I. | 1,622 | (89.51) | 190 | (10.49) | ||
Other | 2,201 | (87.86) | 304 | (12.14) | ||
TB type | Sputum smear (+) pul TB | 13,797 | (87.63) | 1,948 | (12.37) | < 0.0001 |
Sputum smear (−) pul TB | 21,426 | (91.28) | 2,047 | (8.72) | ||
Extra–pul TB | 5,840 | (93.95) | 376 | (6.05) | ||
Medication | Only Group 1 drugs | 39,248 | (90.69) | 4,028 | (9.31) | <.0001 |
With Groups 2–5 drugs | 1,815 | (84.11) | 343 | (15.89) | ||
Region | 1 | 11,139 | (92.17) | 946 | (7.83) | < 0.0001 |
2 | 3,896 | (85.99) | 635 | (14.01) | ||
3 | 1,946 | (90.30) | 209 | (9.70) | ||
4 | 1,671 | (90.13) | 183 | (9.87) | ||
5 | 1,290 | (93.07) | 96 | (6.93) | ||
6 | 943 | (89.98) | 105 | (10.02) | ||
7 | 617 | (90.60) | 64 | (9.40) | ||
8 | 6,228 | (92.31) | 519 | (7.69) | ||
9 | 1,899 | (89.15) | 231 | (10.85) | ||
10 | 1,156 | (91.38) | 109 | (8.62) | ||
11 | 1,658 | (90.06) | 183 | (9.94) | ||
12 | 1,930 | (91.86) | 171 | (8.14) | ||
13 | 1,690 | (86.84) | 256 | (13.16) | ||
14 | 1,892 | (89.84) | 214 | (10.16) | ||
15 | 2,735 | (86.63) | 422 | (13.37) | ||
16 | 373 | (93.02) | 28 | (6.98) | ||
Total | 41,063 | (90.38) | 4,371 | (9.62) |
OR (95% CI) | ||
---|---|---|
Sex | Men | 1.33 (1.24–1.43) |
Women | 1 | |
Age (y) | 0–9 | 0.43 (0.20–0.93) |
10–19 | 1 | |
20–29 | 1.07 (0.91–1.27) | |
30–39 | 1.10 (0.93–1.31) | |
40–49 | 1.20 (1.01–1.42) | |
50–59 | 1.02 (0.86–1.22) | |
60–69 | 1.04 (0.87–1.23) | |
≥70 | 0.90 (0.76–1.07) | |
Medical facilities | Public | 1 |
Private | 1.23 (1.14–1.33) | |
Registration type | New | 1 |
Relapse | 1.76 (1.61–1.91) | |
T.A.F. | 2.02 (1.50–2.72) | |
T.A.D. | 3.18 (2.64–3.83) | |
T.I. | 1.23 (1.05–1.44) | |
Other | 1.42 (1.25–1.61) | |
Tuberculosis type | Sputum smear (+) pul TB | 1.42 (1.33–1.52) |
Sputum smear (−) pul TB | 1 | |
Extrapulmonary TB | 0.70 (0.62–0.78) | |
Medication | Only Group 1 drugs | 1 |
With Groups 2–5 drugs | 1.32 (1.16–1.50) | |
Region | 1 | 1 |
2 | 1.85 (1.66–2.06) | |
3 | 1.19 (1.02–1.42) | |
4 | 1.20 (1.01–1.42) | |
5 | 0.85 (0.69–1.06) | |
6 | 1.23 (0.99–1.52) | |
7 | 1.20 (0.92–1.57) | |
8 | 0.98 (0.87–1.10) | |
9 | 1.42 (1.21–1.65) | |
10 | 1.06 (0.86–1.30) | |
11 | 1.29 (1.09–1.53) | |
12 | 1.06 (0.90–1.26) | |
13 | 1.71 (1.47–1.99) | |
14 | 1.28 (1.09–1.50) | |
15 | 1.66 (1.47–1.88) | |
16 | 0.85 (0.58–1.26) |
OR (95% CI) | ||
---|---|---|
Sex | Men | 1.32 (1.14–1.52) |
Women | 1 | |
Age (y) | 0–9 | 3.22 (0.32–32.27) |
10–19 | 1 | |
20–29 | 1.02 (0.78–1.35) | |
30–39 | 0.99 (0.75–1.32) | |
40–49 | 0.96 (0.73–1.28) | |
50–59 | 0.98 (0.73–1.33) | |
60–69 | 1.02 (0.76–1.38) | |
≥ 70 | 0.81 (0.60–1.09) | |
Registration type | New | 1 |
Relapse | 1.87 (1.60–2.18) | |
T.A.F. | 3.35 (0.47–23.82) | |
T.A.D. | 2.32 (1.64–3.29) | |
T.I. | 1.09 (0.81–1.47) | |
Other | 1.30 (0.85–1.98) | |
Tuberculosis type | Sputum smear (+) pul TB | 1.66 (1.45–1.88) |
Sputum smear (−) pul TB | 1 | |
Extrapulmonary TB | 0.81 (0.45–1.48) | |
Outcome | Cure | 1 |
Complete | 1.39 (0.92–2.11) | |
Failure | 10.26 (5.95–17.68) | |
Default | 3.77 (3.03–4.68) | |
Transfer out | 1.42 (1.17–1.73) | |
Other | 2.41 (1.80–3.25) | |
Region | 1 | 1 |
2 | 1.23 (0.96–1.58) | |
3 | 1.25 (0.89–1.75) | |
4 | 0.77 (0.54–1.09) | |
5 | 1.63 (1.03–2.57) | |
6 | 1.40 (0.94–2.09) | |
7 | 0.73 (0.40–1.31) | |
8 | 1.03 (0.84–1.28) | |
9 | 1.18 (0.84–1.68) | |
10 | 0.99 (0.68–1.45) | |
11 | 1.44 (1.05–1.97) | |
12 | 0.90 (0.62–1.30) | |
13 | 1.47 (1.10–1.96) | |
14 | 1.35 (1.02–1.79) | |
15 | 1.77 (1.35–2.32) | |
16 | 0.57 (0.30–1.09) |
Relapse | p | |||||
---|---|---|---|---|---|---|
No | Yes | |||||
Sex | Men | 7,511 | (90.0) | 839 | (10.0) | < 0.0001 |
Women | 3,901 | (93.2) | 285 | (6.8) | ||
Age (y) | 0–9 | 4 | (80.0) | 1 | (20.0) | 0.002 |
10–19 | 1,115 | (93.5) | 78 | (6.5) | ||
20–29 | 2,377 | (91.6) | 218 | (8.4) | ||
30–39 | 1,855 | (90.7) | 190 | (9.3) | ||
40–49 | 1,762 | (89.8) | 200 | (10.2) | ||
50–59 | 1,195 | (89.7) | 138 | (10.3) | ||
60–69 | 1,411 | (90.0) | 156 | (10.0) | ||
≥ 70 | 1,693 | (92.2) | 143 | (7.8) | ||
Registration | New | 8,684 | (92.5) | 705 | (7.5) | < 0.0001 |
Type | Relapse | 1,655 | (85.1) | 289 | (14.9) | |
T.A.F | 3 | (60.0) | 2 | (40.0) | ||
T.A.D | 178 | (78.8) | 48 | (21.2) | ||
T.I | 677 | (92.6) | 54 | (7.4) | ||
Other | 215 | (89.2) | 26 | (10.8) | ||
TB type | Sputum smear (+) pul TB | 4,585 | (88.2) | 616 | (11.8) | < 0.0001 |
Sputum smear (−) pul TB | 6,615 | (93.0) | 496 | (7.0) | ||
Extrapulmonary TB | 212 | (94.6) | 12 | (5.4) | ||
Outcome | Cure | 9,366 | (92.7) | 735 | (7.3) | < 0.0001 |
Complete | 217 | (88.9) | 27 | (11.1) | ||
Failure | 28 | (50.0) | 28 | (50.0) | ||
Default | 428 | (76.0) | 135 | (24.0) | ||
Transfer out | 1,083 | (88.6) | 139 | (11.4) | ||
Other | 290 | (82.9) | 60 | (17.1) | ||
Region | 1 | 2,109 | (91.54) | 195 | (8.46) | 0.0002 |
2 | 967 | (89.37) | 115 | (10.63) | ||
3 | 430 | (89.77) | 49 | (10.23) | ||
4 | 606 | (93.66) | 41 | (6.34) | ||
5 | 212 | (89.83) | 24 | (10.17) | ||
6 | 277 | (89.35) | 33 | (10.65) | ||
7 | 223 | (94.49) | 13 | (5.51) | ||
8 | 2,422 | (92.09) | 208 | (7.91) | ||
9 | 468 | (90.87) | 47 | (9.13) | ||
10 | 438 | (92.41) | 36 | (7.59) | ||
11 | 539 | (89.68) | 62 | (10.32) | ||
12 | 491 | (92.99) | 37 | (7.01) | ||
13 | 667 | (89.65) | 77 | (10.35) | ||
14 | 716 | (89.50) | 84 | (10.50) | ||
15 | 655 | (87.68) | 92 | (12.32) | ||
16 | 192 | (94.58) | 11 | (5.42) | ||
Total | 11,412 | (91.0) | 1,124 | (9.0) |
pul = pulmonary; T.A.D. = treatment after default; T.A.F. = treatment after failure; T.I. = transfer in.
Data are presented as T.A.D. = treatment after default; T.A.F. = treatment after failure; TB = tuberculosis; T.I. = transfer in; pul = pulmonary.
CI = confidence interval; OR = odds ratio; T.A.D. = treatment after default; T.A.F. = treatment after failure; T.I. = transfer in; pul = pulmonary.
CI = confidence interval; OR = odds ratio; pul = pulmonary; T.A.F. = treatment after failure, T.A.D. = treatment after default, T.I. = transfer in.
Data are presented as pul = pulmonary; T.A.D. = treatment after default, T.A.F. = treatment after failure; T.I. = transfer in.